Recently, expression of MT3-encoding mRNA MT3 has been associated with a worse prognosis of breast cancer and neuroblastoma patients, and it has also been shown that MT3 expression tightly correlates with the poor outcomes of chemotherapy [25–27]. This evidence concerns the gene MT3 and breast carcinoma.